Showing results (831-840 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|March 12, 2022
Genetic and phenotypic profiling of supranormal ejection fraction reveals decreased survival and underdiagnosed heart failureIain S Forrest, Ghislain Rocheleau, Shantanu Bafna, et al.
European Journal of Heart Failure|April 4, 2022
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodiesAnna Baritussio, Alessandro Schiavo, Cristina Basso, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
European Journal of Heart Failure|May 31, 2018
PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot studyUlrich Laufs, Nina Griese-Mammen, Katrin Krueger, et al.
European Journal of Heart Failure|May 16, 2018
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetesAbhinav Sharma, Sana M Al-Khatib, Justin A Ezekowitz, et al.
European Journal of Heart Failure|May 1, 2018
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trialSusana Ravassa, Tobias Trippel, Doris Bach, et al.
European Journal of Heart Failure|April 17, 2019
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Marija Polovina, Johann Bauersachs, et al.
European Journal of Heart Failure|June 13, 2014
Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trialJohann Altenberger, John T Parissis, Angelika Costard-Jaeckle, et al.
European Journal of Heart Failure|May 22, 2014
Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HFGaetano M De Ferrari, Anton E Tuinenburg, Stephen Ruble, et al.
European Journal of Heart Failure|March 26, 2010
Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failureLiza S M Wong, Jardi Huzen, Pim van der Harst, et al.
Pageof 398